Biotech

All Articles

Ultragenyx adjusts gene therapy application to dial up effectiveness

.A minority of patients taking Ultragenyx Pharmaceutical's Wilson health condition genetics therapy ...

Biopharma cutback rate maintains in Q3: Fierce Biotech review

.As summer months heat energy looks to cool winds, wishes that this year will deliver prevalent sect...

J &amp J drops stage 2 dengue candidate in most recent shift from vaccines

.Johnson &amp Johnson's deprioritization of its infectious disease pipeline has actually declared an...

Relay loses 10% of personnel after earlier discharges in July

.Preciseness medication biotech Relay Therapeutics is shedding around 10% of its workforce in effort...

Pentixapharm credit ratings $22M IPO to loan radiopharma trials

.Pentixapharm has introduced nearly 20 thousand euros ($ 22 million) from an IPO, with the German bi...

Lundbeck faucets Charles Waterway for AI-enabled neuro drug discovery

.Lundbeck has actually tapped Charles Waterway Laboratories' artificial intelligence capacities to a...

Big pharma, biotech 'won't always be cooperative' in AI: S&ampP

.Large Pharma is committing heavily in AI to slash development timelines and foster advancement. But...

I &amp I biotech Triveni elevates $115M for preclinical antitoxins

.Triveni Biography has roped in $115 thousand in set B funds to accelerate preclinical antibody prog...

IGM rotates coming from cancer to autoimmune, agitating C-suite

.IGM Biosciences ended in 2013 laying off staff as well as simplifying its cancer pipeline. Currentl...

Shattuck axes CD47 program over unstable efficiency records, gives up 40% of staff as well as drops Ono deal

.Shattuck Labs has knocked an additional nail into the coffin of CD47. After finding a "small" resul...